Minor intron splicing is critical for survival of lethal prostate cancer Journal Article


Authors: Augspach, A.; Drake, K. D.; Roma, L.; Qian, E.; Lee, S. R.; Clarke, D.; Kumar, S.; Jaquet, M.; Gallon, J.; Bolis, M.; Triscott, J.; Galván, J. A.; Chen, Y.; Thalmann, G. N.; Kruithof-de Julio, M.; Theurillat, J. P. P.; Wuchty, S.; Gerstein, M.; Piscuoglio, S.; Kanadia, R. N.; Rubin, M. A.
Article Title: Minor intron splicing is critical for survival of lethal prostate cancer
Abstract: The evolutionarily conserved minor spliceosome (MiS) is required for protein expression of ∼714 minor intron-containing genes (MIGs) crucial for cell-cycle regulation, DNA repair, and MAP-kinase signaling. We explored the role of MIGs and MiS in cancer, taking prostate cancer (PCa) as an exemplar. Both androgen receptor signaling and elevated levels of U6atac, a MiS small nuclear RNA, regulate MiS activity, which is highest in advanced metastatic PCa. siU6atac-mediated MiS inhibition in PCa in vitro model systems resulted in aberrant minor intron splicing leading to cell-cycle G1 arrest. Small interfering RNA knocking down U6atac was ∼50% more efficient in lowering tumor burden in models of advanced therapy-resistant PCa compared with standard antiandrogen therapy. In lethal PCa, siU6atac disrupted the splicing of a crucial lineage dependency factor, the RE1-silencing factor (REST). Taken together, we have nominated MiS as a vulnerability for lethal PCa and potentially other cancers. © 2023 The Author(s)
Keywords: prostate cancer; androgen receptor; therapy resistance; therapeutics; splicing; castration-resistant prostate cancer; snrnas; crpc; rest; neuroendocrine prostate cancer; lineage plasticity; minor spliceosome; minor intron splicing; small-cell prostate cancer; u6atac sirna
Journal Title: Molecular Cell
Volume: 83
Issue: 12
ISSN: 1097-2765
Publisher: Cell Press  
Date Published: 2023-06-15
Start Page: 1983
End Page: 2002.e11
Language: English
DOI: 10.1016/j.molcel.2023.05.017
PUBMED: 37295433
PROVIDER: scopus
PMCID: PMC10637423
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yu Chen
    133 Chen